CORD-19:ee0a7632371a08727d41e55aad7d621daeceef7d / 560991-561226 JSONTXT

{"project":"CORD-19-Sentences","denotations":[{"id":"T93599","span":{"begin":0,"end":235},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Some of the putative resistance mechanisms have provided novel therapeutic strategies as PIM1 inhibitors (AZD-1208) produced highly synergistic inhibitory effects against NB cells when applied with ALK inhibitors at low concentrations."}

{"project":"CORD-19_Custom_license_subset","denotations":[{"id":"T195","span":{"begin":0,"end":235},"obj":"Sentence"}],"text":"Some of the putative resistance mechanisms have provided novel therapeutic strategies as PIM1 inhibitors (AZD-1208) produced highly synergistic inhibitory effects against NB cells when applied with ALK inhibitors at low concentrations."}

{"project":"CORD-19-PD-HP","denotations":[{"id":"T1122","span":{"begin":171,"end":173},"obj":"Phenotype"}],"attributes":[{"id":"A1122","pred":"hp_id","subj":"T1122","obj":"http://purl.obolibrary.org/obo/HP_0003006"}],"text":"Some of the putative resistance mechanisms have provided novel therapeutic strategies as PIM1 inhibitors (AZD-1208) produced highly synergistic inhibitory effects against NB cells when applied with ALK inhibitors at low concentrations."}

{"project":"CORD-19-PD-MONDO","denotations":[{"id":"T2693","span":{"begin":171,"end":173},"obj":"Disease"},{"id":"T19242","span":{"begin":171,"end":173},"obj":"Disease"}],"attributes":[{"id":"A2693","pred":"mondo_id","subj":"T2693","obj":"http://purl.obolibrary.org/obo/MONDO_0005072"},{"id":"A75664","pred":"mondo_id","subj":"T19242","obj":"http://purl.obolibrary.org/obo/MONDO_0005072"}],"text":"Some of the putative resistance mechanisms have provided novel therapeutic strategies as PIM1 inhibitors (AZD-1208) produced highly synergistic inhibitory effects against NB cells when applied with ALK inhibitors at low concentrations."}